Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Merck & Company (MRK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 160,773,808
  • Shares Outstanding, K 2,696,190
  • Annual Sales, $ 40,122 M
  • Annual Income, $ 2,394 M
  • 36-Month Beta 0.78
  • Price/Sales 4.04
  • Price/Cash Flow 10.52
  • Price/Book 4.74

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.83 +12.95%
on 04/03/18
61.00 -2.18%
on 04/24/18
+5.63 (+10.42%)
since 03/26/18
3-Month
52.83 +12.95%
on 04/03/18
62.14 -3.97%
on 01/29/18
-2.37 (-3.82%)
since 01/26/18
52-Week
52.83 +12.95%
on 04/03/18
66.41 -10.15%
on 09/18/17
-3.03 (-4.83%)
since 04/26/17

Most Recent Stories

More News
Moleculin Announces New Data for Immuno-Stimulating Drug to be Presented at International Conference

HOUSTON, TX--(Marketwired - April 26, 2018) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug...

MRK : 59.67 (+0.07%)
MBRX : 1.83 (+2.23%)
Fish & Richardson Wins Federal Circuit Affirmance of Reversal of $200 Million Damages Against Gilead After Merck's "Unclean Hands"

Fish & Richardson won a unanimous Federal Circuit opinion today that affirmed its June 2016 post-trial wipe-out of a $200 million jury verdict against client Gilead Sciences, Inc. after proving Merck had...

MRK : 59.67 (+0.07%)
Will Pfizer's (PFE) Earnings Beat Estimates Again in Q1?

While Pfizer's (PFE) new drugs like Ibrance and Xeljanz are likely to drive Q1 sales, genericization of key drugs and supply shortages in legacy Hospira products will hurt the same.

CELG : 89.50 (+0.34%)
MRK : 59.67 (+0.07%)
PFE : 36.72 (+0.11%)
BMY : 52.05 (+0.56%)
What's in the Cards for Merck (MRK) This Earnings Season?

Merck's (MRK) new products like Keytruda and Bridion are likely to drive first-quarter sales. However, headwinds remain in the form genericization of key drugs and increasing competition.

MRK : 59.67 (+0.07%)
PFE : 36.72 (+0.11%)
GSK : 39.80 (+1.74%)
BMY : 52.05 (+0.56%)
HPV Vaccine Market 2022 Demand, Key Players- Merck and Co., GlaxoSmithKline

PUNE, India, April 25, 2018 /PRNewswire/ --

MRK : 59.67 (+0.07%)
GSK : 39.80 (+1.74%)
Watch for Shares of Merck & Co (MRK) to Approach Resistance at $61.29

Shares of Merck & Co (NYSE:MRK) have bullishly opened above the pivot of $60.10 today and have reached the first resistance level of $60.77. Analysts will be watching for a cross of the next upside pivot...

MRK : 59.67 (+0.07%)
Lilly (LLY) Tops on Q1 Earnings, Raises '18 View, Stock Up

Eli Lilly (LLY) beats estimates for both earnings and sales in Q1 and raises guidance for 2018. Shares rise in pre-market trading.

MRK : 59.67 (+0.07%)
LLY : 81.14 (+1.31%)
INCY : 62.99 (+1.03%)
PFE : 36.72 (+0.11%)
Global Microbiology Laboratory Supplies Market 2018-2022 - Key Vendors are Becton, Dickinson and Company, bioMrieux, Danaher, Merck, QIAGEN & Thermo Fisher Scientific

The "Global Microbiology Laboratory Supplies Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

MRK : 59.67 (+0.07%)
Today's Research Reports on Stocks to Watch: Merck and Akorn

NEW YORK, NY / ACCESSWIRE / April 24, 2018 / Akorn shares were destroyed in Monday trading as traders reacted to the news that Fresenius has ditched its plans to buy the company. Shares of Merck however...

MRK : 59.67 (+0.07%)
Relatively Good Performance Detected in Shares of Omeros Corp in the Pharmaceuticals Industry (OMER , MRK , HZNP , DEPO , LLY )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

HZNP : 13.69 (-0.58%)
MRK : 59.67 (+0.07%)
OMER : 13.72 (-4.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies...

See More

Key Turning Points

2nd Resistance Point 60.49
1st Resistance Point 60.06
Last Price 59.67
1st Support Level 59.06
2nd Support Level 58.50

See More

52-Week High 66.41
Fibonacci 61.8% 61.22
Last Price 59.67
Fibonacci 50% 59.62
Fibonacci 38.2% 58.02
52-Week Low 52.83

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar